microdose glp-1 menopause Microdosing for GLP-1s for Menopause-Related Weight Gain GLP-1 Agonists in Perimenopause: Unique

This podcast is for informational purposes only and is not intended to replace professional medical advice.If you have a question for Dr

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

Various pre-clinical and phase-2 studies have indicated the therapeutic potential of semaglutide in non-alcoholic steatohepatitis and neurodegenerative disorders like Parkinsons and Alzheimers disease

And for those who are more sensitive, new agents like cagrilintide and eloralintide, both amylin receptor agonists, look promising because they shouldnt produce these same heart rate effects